Metraipolis › archive › dc_a590aa28db26

Romiplostim-N01 for cancer therapy-induced thrombocytopenia: A propensity score-matched cohort study — Europe PMC PMID:42216387

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42216387
DOI
10.1097/md.0000000000048855
License (as archived)
solo-consultazione
Archived
2026-11-02T20:21:08.986Z
SHA-256 of the archived text
bb4ac80e1cdfef8a7091e9ab7b0d1f21701b5be3366309c63e7250b69fea4f4b
Stable URL of this page
https://metraipolis.com/documento/dc_a590aa28db26

How to cite

Romiplostim-N01 for cancer therapy-induced thrombocytopenia: A propensity score-matched cohort study — Europe PMC PMID:42216387 — Europe PMC (en), https://europepmc.org/article/MED/42216387 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a590aa28db26 (Metraipolis archive dc_a590aa28db26, sha256 bb4ac80e1cdfef8a7091e9ab7b0d1f21701b5be3366309c63e7250b69fea4f4b)
BibTeX
@misc{dca590aa28db26,
  title = {Romiplostim-N01 for cancer therapy-induced thrombocytopenia: A propensity score-matched cohort study — Europe PMC PMID:42216387},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42216387},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a590aa28db26; sha256 bb4ac80e1cdfef8a7091e9ab7b0d1f21701b5be3366309c63e7250b69fea4f4b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42216387. Agents can read the archived copy with the MCP tool read_document.